1. Clinical and Anthropometric Characteristics of Non-obese NAFLD Subjects in Japan Shoda, Junichi, Shida, Takashi, Oshida, Natsumi, Suzuki, Hideo, Okada, Kosuke, Watahiki, Takahisa, Oh, Sechang, Kim, Taeho, Isobe, Tomonori, Okamoto, Yoshikazu, Ariizumi, Shun-ichi, Yamamoto, Masakazu Hepatology Research 50 (9) 1032 - 1046 (2020)
2. Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice Watahiki, Takahisa, Okada, Kosuke, Warabi, Eiji, Nagaoka, Tsugumi, Suzuki, Hideo, Ishige, Kazunori, Yanagawa, Toru, Takahashi, Satoru, Mizokami, Yuji, Tokushige, Katsutoshi, Ariizumi, Shun-Ichi, Yamamoto, Masakazu, Shoda, Junichi Experimental animals 69 (4) 395 - 406 (2020)
3. Effect of a single bout of exercise on clock gene expression in human leukocyte Tanaka, Yoshiaki, Ogata, Hitomi, Kayaba, Momoko, Ando, Akira, Park, Insung, Yajima, Katsuhiko, Araki, Akihiro, Suzuki, Chihiro, Osumi, Haruka, Zhang, Simeng, Ishihara, Asuka, Takahashi, Keigo, Shoda, Junichi, Nabekura, Yoshiharu, Satoh, Makoto, Tokuyama, Kumpei JOURNAL OF APPLIED PHYSIOLOGY 128 (4) 847 - 854 (2020)
4. Urinary Levels of Titin-N Fragment, a Skeletal Muscle Damage Marker, are Increased in Subjects with Nonalcoholic Fatty Liver Disease Oshida, Natsumi, Shida, Takashi, Oh, Sechang, Kim, Taeho, Isobe, Tomonori, Okamoto, Yoshikazu, Kamimaki, Takashi, Okada, Kosuke, Suzuki, Hideo, Ariizumi, Shun-Ichi, Yamamoto, Masakazu, Shoda, Junichi Scientific reports 9 (1) 19498 (2019)
5. Whole-body vibration for patients with nonalcoholic fatty liver disease: a 6-month prospective study Oh, Sechang, Oshida, Natsumi, Someya, Noriko, Maruyama, Tsuyoshi, Isobe, Tomonori, Okamoto, Yoshikazu, Kim, Taeho, Kim, Bokun, Shoda, Junichi Physiological reports 7 (9) (2019)
6. Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease Shida, Takashi, Oshida, Natsumi, Oh, Sechang, Okada, Kosuke, Shoda, Junichi Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 12 495 - 503 (2019)
7. Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate Yamashita-Kashima, Yoriko, Yoshimura, Yasushi, Fujimura, Takaaki, Shu, Sei, Yanagisawa, Mieko, Yorozu, Keigo, Furugaki, Koh, Higuchi, Ryota, Shoda, Junichi, Harada, Naoki Cancer chemotherapy and pharmacology 83 (4) 659 - 671 (2019)
8. 運動は抗酸化ストレス応答を賦活化して脂肪肝の肝病態を改善する 正田,純一 体力科学 68 (1) 32 - 32 (2019)
9. Urinary levels of titan-N fragment are increased in subjects with NAFLD. Shoda,Junichi Sci Reps 9 19498 (2019)
10. 性差による臨床像の差違—胆石症 正田,純一 胆と膵 515 - 518 (2018)

researchmap の論文リストを表示する Show the publication list on researchmap